EUVIMEDEUVIMED entdecken
Open Access

Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022

Welmoed van Loon, Bertin C Bisimwa, Valéry Byela, Rebecca Kirby, Patrick M Bugeme, Aimé Balagizi, David Lupande, Espoir B Malembaka, Frank P Mockenhaupt, Esto Bahizire

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.23-0740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Welmoed van Loon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of International Health, Center for Global Health, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Antimalarials, Artemisinins, Malaria, Falciparum. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Partial artemisinin resistance has emerged in East Africa, posing a threat to malaria control across the continent. The Democratic Republic of the Congo carries one of the heaviest malaria burdens globally, and the South Kivu province directly borders current artemisinin resistance hot spots, but indications of such resistance have not been observed so far. We assessed molecular markers of antimalarial drug resistance in 256 Plasmodium falciparum isolates collected in 2022 in South Kivu, Democratic Republic of the Congo. One isolate carried the P. falciparum Kelch-13 469Y variant, a marker associated with partial artemisinin resistance and decreased lumefantrine susceptibility in Uganda. In addition, the multidrug resistance-1 mutation pattern suggested increased lumefantrine tolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsArtemisininsMalaria, FalciparumHumansPlasmodium falciparumDemocratic Republic of the CongoLumefantrineUgandaDrug ResistanceProtozoan Proteins

Substanzen

AntimalarialsartemisininArtemisininsLumefantrineProtozoan Proteins

Autor:innen und Institutionen

  • Institute of International Health, Center for Global Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
  • Institut Supérieur des Techniques Médicales de Bukavu, Bukavu, Democratic Republic of the Congo.
  • University of California, San Diego School of Medicine, San Diego, California.
  • Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
  • Hôpital Général de Référence de Nyantende, Nyantende, Democratic Republic of the Congo.

Zitieren

APA

van Loon, W., Bisimwa, B. C., Byela, V., Kirby, R., Bugeme, P. M., Balagizi, A., Lupande, D., Malembaka, E. B., Mockenhaupt, F. P., & Bahizire, E. (2024). Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0740

Vancouver

van Loon W, Bisimwa BC, Byela V, Kirby R, Bugeme PM, Balagizi A, et al. Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0740

BibTeX
@article{vanLoon2024,
  author = {van Loon, Welmoed and Bisimwa, Bertin C and Byela, Valéry and Kirby, Rebecca and Bugeme, Patrick M and Balagizi, Aimé and Lupande, David and Malembaka, Espoir B and Mockenhaupt, Frank P and Bahizire, Esto},
  title = {Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.23-0740}
}
Kostenlos starten →